Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.

Abstract

These results indicate the feasibility and safety of bone marrow gene therapy with a potentially therapeutic gene, the MDR gene.